Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults
Long Term Safety and Efficacy of KSM-66 Ashwagandha (Standardized Root Extract of Withania Somnifera) in Adults: A Prospective, Observational Study
Sponsor: SF Research Institute, Inc.
A observational or N/A phase clinical study on All, this trial is completed. The trial is conducted by SF Research Institute, Inc. and has accumulated 5 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Dec 2025 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2025 — Dec 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
First recorded
Feb 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- SF Research Institute, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .